|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 94 No. 7 (October 1), 1999:
pp. 2343-2356
The Monoclonal Antibody 97A6 Defines a Novel Surface Antigen Expressed
on Human Basophils and Their Multipotent and Unipotent Progenitors
Hans-Jörg Bühring,
Paul J. Simmons,
Melanie Pudney,
Robert Müller,
David Jarrossay,
Andreas van Agthoven,
Martin Willheim,
Wolfram Brugger,
Peter Valent, and
Lothar Kanz
From the Department of Medicine, Division of Hematology and Oncology,
University of Tübingen, Tübingen, Germany; Hanson Centre
for Cancer Research, Matthew Roberts Laboratory, Institute of Medical
and Veterinary Sciences, Adelaide, South Australia, Australia;
Immunotech, S.A., a Beckman-Coulter company, Marseille, France;
Department of Internal Medicine I, Division of Hematology and
Hemostaseology, University of Vienna, Vienna, Austria; and Institute of
General and Experimental Pathology, University of Vienna, Vienna,
Austria.
Basophils (Ba) and mast cells (MC) are important effector cells of
inflammatory reactions. Both cell types derive from CD34+
hematopoietic progenitors. However, little is known about the cell
subsets that become committed to and give rise to Ba and/or MC. We have
generated a monoclonal antibody (MoAb), 97A6, that specifically detects
human Ba, MC (lung, skin), and their CD34+ progenitors.
Other mature hematopoietic cells (neutrophils, eosinophils, monocytes,
lymphocytes, platelets) did not react with MoAb 97A6, and sorting of
97A6+ peripheral blood (PB) and bone marrow (BM) cells
resulted in an almost pure population (>98%) of Ba. Approximately
1% of CD34+ BM and PB cells was found to be
97A6+. Culture of sorted
CD34+97A6+ BM cells in semisolid medium
containing phytohemagglutinin-stimulated leukocyte
supernatant for 16 days (multilineage assay) resulted in the formation
of pure Ba colonies (10 of 40), Ba-eosinophil colonies (7 of 40),
Ba-macrophage colonies (3 of 40), and multilineage Ba-eosinophil-macrophage and/or neutrophil colonies (12 of 40). In
contrast, no Ba could be cultured from
CD34+97A6 cells. Liquid culture of
CD34+ PB cells in the presence of 100 ng/mL interleukin
(IL)-3 (Ba progenitor assay) resulted in an increase of
97A6+ cells, starting from 1% of day-0 cells to almost
70% (basophils) after day 7. Culture of sorted BM
CD34+97A6+ cells in the presence of 100 ng/mL stem cell factor (SCF) for 35 days (mast cell progenitor assay)
resulted in the growth of MC (>30% on day 35). Anti-IgE-induced IgE
receptor cross-linking on Ba for 15 minutes resulted in a 4-fold to
5-fold upregulation of 97A6 antigen expression. These data show that
the 97A6-reactive antigen plays a role in basophil activation and is
expressed on multipotent CD34+ progenitors, MC
progenitors, Ba progenitors, as well as on mature Ba and tissue MC. The
lineage-specificity of MoAb 97A6 suggests that this novel marker may be
a useful tool to isolate and analyze Ba/MC and their progenitors.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
Y. Mori, H. Iwasaki, K. Kohno, G. Yoshimoto, Y. Kikushige, A. Okeda, N. Uike, H. Niiro, K. Takenaka, K. Nagafuji, et al.
Identification of the human eosinophil lineage-committed progenitor: revision of phenotypic definition of the human common myeloid progenitor
J. Exp. Med.,
January 16, 2009;
206(1):
183 - 193.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. J. Aichberger, M. Mayerhofer, A. Vales, M.-T. Krauth, K. V. Gleixner, M. Bilban, H. Esterbauer, K. Sonneck, S. Florian, S. Derdak, et al.
The CML-related oncoprotein BCR/ABL induces expression of histidine decarboxylase (HDC) and the synthesis of histamine in leukemic cells
Blood,
November 15, 2006;
108(10):
3538 - 3547.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H Agis, M-T Krauth, I Mosberger, L Mullauer, I Simonitsch-Klupp, L B Schwartz, D Printz, A Bohm, G Fritsch, H-P Horny, et al.
Enumeration and immunohistochemical characterisation of bone marrow basophils in myeloproliferative disorders using the basophil specific monoclonal antibody 2D7
J. Clin. Pathol.,
April 1, 2006;
59(4):
396 - 402.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Schiemann, T. A. Grimm, J. Hoch, R. Gross, B. Lindner, F. Petersen, S. Bulfone-Paus, and E. Brandt
Mast cells and neutrophils proteolytically activate chemokine precursor CTAP-III and are subject to counterregulation by PF-4 through inhibition of chymase and cathepsin G
Blood,
March 15, 2006;
107(6):
2234 - 2242.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Infantino, B. Moepps, and M. Thelen
Expression and Regulation of the Orphan Receptor RDC1 and Its Putative Ligand in Human Dendritic and B Cells
J. Immunol.,
February 15, 2006;
176(4):
2197 - 2207.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Arinobu, H. Iwasaki, M. F. Gurish, S.-i. Mizuno, H. Shigematsu, H. Ozawa, D. G. Tenen, K. F. Austen, and K. Akashi
Developmental checkpoints of the basophil/mast cell lineages in adult murine hematopoiesis
PNAS,
December 13, 2005;
102(50):
18105 - 18110.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. S. Akimov, A. Ramezani, T. S. Hawley, and R. G. Hawley
Bypass of Senescence, Immortalization, and Transformation of Human Hematopoietic Progenitor Cells
Stem Cells,
September 1, 2005;
23(9):
1423 - 1433.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. C. Jamur, A. C. G. Grodzki, E. H. Berenstein, M. M. Hamawy, R. P. Siraganian, and C. Oliver
Identification and characterization of undifferentiated mast cells in mouse bone marrow
Blood,
June 1, 2005;
105(11):
4282 - 4289.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Monneret, R. Boumiza, S. Gravel, C. Cossette, J. Bienvenu, J. Rokach, and W. S. Powell
Effects of Prostaglandin D2 and 5-Lipoxygenase Products on the Expression of CD203c and CD11b by Basophils
J. Pharmacol. Exp. Ther.,
February 1, 2005;
312(2):
627 - 634.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Kambe, H. Hiramatsu, M. Shimonaka, H. Fujino, R. Nishikomori, T. Heike, M. Ito, K. Kobayashi, Y. Ueyama, N. Matsuyoshi, et al.
Development of both human connective tissue-type and mucosal-type mast cells in mice from hematopoietic stem cells with identical distribution pattern to human body
Blood,
February 1, 2004;
103(3):
860 - 867.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Majlesi, P. Samorapoompichit, A. W. Hauswirth, G.-H. Schernthaner, M. Ghannadan, M. Baghestanian, A. Rezaie-Majd, R. Valenta, W. R. Sperr, H.-J. Buhring, et al.
Cerivastatin and atorvastatin inhibit IL-3-dependent differentiation and IgE-mediated histamine release in human basophils and downmodulate expression of the basophil-activation antigen CD203c/E-NPP3
J. Leukoc. Biol.,
January 1, 2003;
73(1):
107 - 117.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Arock, E. Schneider, M. Boissan, V. Tricottet, and M. Dy
Differentiation of human basophils: an overview of recent advances and pending questions
J. Leukoc. Biol.,
April 1, 2002;
71(4):
557 - 564.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H.-J. Buhring, M. Seiffert, C. Giesert, A. Marxer, L. Kanz, P. Valent, and K. Sano
The basophil activation marker defined by antibody 97A6 is identical to the ectonucleotide pyrophosphatase/phosphodiesterase 3
Blood,
May 15, 2001;
97(10):
3303 - 3305.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. H. Falcone, H. Haas, and B. F. Gibbs
The human basophil: a new appreciation of its role in immune responses
Blood,
December 15, 2000;
96(13):
4028 - 4038.
[Full Text]
[PDF]
|
|
|
|
|
